Endowment Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Endowment Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Sell	5,691 -2,312	-29%	-$397K	0.42%	50
2026 Q1	$1.35M	Buy	8,003 +930	+13%	+$159K	0.6%	43
2025 Q4	$1.19M	Buy	7,073 +1,208	+21%	+$196K	0.55%	46
2025 Q3	$847K	Buy	5,865 +1,280	+28%	+$175K	0.38%	59
2025 Q2	$580K	Buy	4,585 +1,070	+30%	+$131K	0.3%	69
2025 Q1	$450K	Buy	3,515 +1,263	+56%	+$171K	0.29%	72
2024 Q4	$298K	Buy	+2,252	New	+$317K	0.2%	99

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Endowment Wealth Management's IBB Position: Q2 2026 in Review

Endowment Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 29% in Q2 2026, selling an estimated $397K and leaving 5,691 shares worth $1.08M. The position accounts for 0.42% of the portfolio, ranked #50.

Endowment Wealth Management first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.35M in Q1 2026. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Endowment Wealth Management held 5,691 shares of iShares Biotechnology ETF worth $1.08M as of Q2 2026.
Endowment Wealth Management sold 2,312 iShares Biotechnology ETF shares in Q2 2026, an estimated $397K.
iShares Biotechnology ETF made up 0.42% of Endowment Wealth Management's portfolio in Q2 2026, its #50 holding.
Endowment Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
Endowment Wealth Management's iShares Biotechnology ETF position peaked at $1.35M in Q1 2026.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Endowment Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.